drugset / Trial / NCT01776684
Evaluation of EGFR TKI Resistance Mechanism Using Plasma DNA Analysis
Non-randomizedSingle-groupOpen-labelDiagnostic
Summary
To detect resistance gene from serially collected plasma DNA in non-small cell lung cancer harbouring EGFR activating mutation who are being treated with EGFR TKIs by using castPCR method.
Timeline
- Start
- 2012-06
- Primary completion
- 2014-05
- Completion
- 2015-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Afatinib | Small molecule | — | — |
| Background | Erlotinib | Small molecule | — | — |
| Background | Gefitinib | Small molecule | — | — |